Akman Wellness Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-07-2024
- Paid Up Capital ₹ 84.00 K
as on 09-07-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -19.55%
(FY 2022)
- Profit -193.13%
(FY 2022)
- Ebitda -40.86%
(FY 2022)
- Net Worth -52.70%
(FY 2022)
- Total Assets -16.69%
(FY 2022)
About Akman Wellness
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 84.00 K , as per Ministry of Corporate Affairs (MCA) records.
Mansukhbhai Suhagiya and Kamleshbhai Suhagiya serve as directors at the Company.
- CIN/LLPIN
U74999GJ2018PTC101362
- Company No.
101362
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Akman Wellness Private Limited offer?
Akman Wellness Private Limited offers a wide range of products and services, including Common Disease Medicines, Oral Care Products, Salon, Spa Kits & Equipments, Shaving Accessories, Cosmetics, Hair & Beauty Products, Beauty Cosmetics, Ayurvedic, Herbal Oils and Cosmetics, Aloe Vera Cosmetics, Hair Care Products, Hand Sanitizers & Personal Hygiene.
Who are the key members and board of directors at Akman Wellness?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mansukhbhai Suhagiya  | Director | 19-Mar-2018 | Current |
| Kamleshbhai Suhagiya | Director | 27-Jul-2022 | Current |
Financial Performance and Corporate Structure Insights of Akman Wellness.
Akman Wellness Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 19.55% decrease. The company also saw a substantial fall in profitability, with a 193.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 52.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akman Wellness?
In 2020, Akman Wellness had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Akman Biotech Private LimitedActive 6 years 7 monthsMansukhbhai Suhagiya and Kamleshbhai Suhagiya are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Akman Wellness?
Unlock and access historical data on people associated with Akman Wellness, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akman Wellness, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akman Wellness's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
